Encoding Active Antigen-Specific Immune Tolerance Using mRNA-LNPs for the Treatment of Autoimmune Diseases
- Highlighting the advantages of incorporating an active immune modulator into antigen-specific tolerance strategies
- Exploring critical factors in applying mRNA-LNP technology to autoimmune conditions, including challenges and successes targeting immune cell delivery
- Presenting preclinical findings from autoimmune disease models